L-Histidine for Eczema (Atopic Dermatitis)

Oral L-histidine improved atopic dermatitis severity in a single small proof-of-concept trial, based on its role as the precursor to skin natural moisturizing factor.

Overview

Oral L-histidine improved atopic dermatitis severity in a single small proof-of-concept trial, based on its role as the precursor to skin natural moisturizing factor.

Verdict

Insufficient evidence

One small trial and a strong mechanism are not enough. Histidine for eczema is a plausible idea awaiting replication.

How It Works

Histidine is converted in the stratum corneum to urocanic acid and other filaggrin breakdown products that make up natural moisturizing factor, the deficit of which characterizes atopic skin.

Dosing & Protocol

Typical dose

Recommended dose: 4 g daily, as used in the trial
Expected timeframe: Improvements reported over 4 weeks in the available study

Protocol

form: Oral L-histidine powder was used in the trial
duration: The trial ran 4 weeks; no longer-term safety or efficacy data exist
co factor: Treatments with real evidence come first: emollients used generously, topical corticosteroids or calcineurin inhibitors for flares, and trigger avoidance
titration: No titration is justified — there is no dose-ranging evidence and no replication of the original finding
starting dose: Not established. A single small proof-of-concept trial used 4 g daily of oral L-histidine for 4 weeks in adults with atopic dermatitis; this is the studied dose, not a recommendation

Evidence

What the studies say

The mechanistic case is unusually clean: filaggrin mutations are the best-established genetic risk factor for atopic dermatitis, and filaggrin's job is to break down into histidine-derived natural moisturizing factor. A small randomized proof-of-concept study in adults with moderate atopic dermatitis reported roughly a third reduction in disease severity scores after four weeks of 4 g/day oral histidine, with no serious adverse events. That is where the human evidence stops. The trial was small, short and closely tied to the developing commercial product, and no independent replication of comparable quality has followed. Until a larger controlled trial exists, histidine belongs in the experimental column rather than the treatment plan.

Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis

Score: 5/10

2017

systematic_review

Tan SP, Brown SB, Griffiths CEM

L-histidine is rapidly incorporated into filaggrin in skin, and pilot supplementation data suggest reduced atopic dermatitis severity.

View source

Safety

Caveats

{"Single small trial with commercial ties","No independent replication","Can worsen symptoms in histamine-intolerant people"}

Less likely to help if

People whose eczema is driven primarily by contact allergy rather than barrier dysfunction are unlikely to respond.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.